US Edition
Published • loading... • Updated
Scotiabank Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Cantor Fitzgerald raised Gilead Sciences' price target to $155 after a quarterly earnings beat and raised FY2026 guidance, signaling confidence in future growth.
Summary by defenseworld.net
1 Articles
1 Articles
Scotiabank Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target raised by analysts at Scotiabank from $140.00 to $177.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “sector outperform” rating on the biopharmaceutical company’s stock. Scotiabank’s price target would suggest a potential upside of 16.59% from the stock’s current price. A number of other equities analysts have also recently commented…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
